Myung In Pharmaceutical LTD. (KRX:317450)
South Korea
· Delayed Price · Currency is KRW 72,600
-1,100 (-1.49%)
At close: Dec 5, 2025
KRX:317450 Revenue
Myung In Pharmaceutical LTD. had revenue of 72.70B KRW in the quarter ending September 30, 2025, with 10.75% growth. This brings the company's revenue in the last twelve months to 283.31B. In the year 2024, Myung In Pharmaceutical LTD. had annual revenue of 269.43B with 11.18% growth.
Revenue (ttm)
283.31B
Revenue Growth
+11.18%
P/S Ratio
3.74
Revenue / Employee
845.69M
Employees
335
Market Cap
1,059.96B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |